Skip to main content
Log in

Genotyping of patients with phenylketonuria from different regions of Russia for determining BH4 responsiveness

  • Human Genetics
  • Published:
Russian Journal of Genetics Aims and scope Submit manuscript

Abstract

To date, the efficacy of the phenylalanine hydroxylase (PAH) cofactor is proved for the treatment of both BH4-dependent hyperphenylalaninemia and phenylketonuria patients with mutations in the PAH gene. Since the patient’s response depends on the presence of residual PAH enzyme activity, it is advisable to search for mutations in the PAH gene to identify the potential responders and nonresponders to therapy. Four hundred thirty-five phenylketonuria patients from 13 regions of the Russian Federation were genotyped in order to identify responders and nonresponders to tetrahydrobiopterin (BH4) therapy. According to the results of this study, the number of probable nonresponders to the BH4 treatment exceeds 50% owing to a higher overall allelic frequency of “severe” PAH gene mutations. Responder patients with two “mild” mutations in the PAH gene were identified (1.6%).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Blau, N., Hennermann, J.B., Langenbeck, U., and Lichter-Konecki, U., Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies, Mol. Genet. Metab., 2011, vol. 104, suppl., pp. S2—S9. doi 10.1016/j.ymgme.2011.08.017

    Google Scholar 

  2. Guttler, F., Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood, Acta Paediatr. Scand. Suppl., 1980, vol. 280, pp. 1–80.

    CAS  PubMed  Google Scholar 

  3. Bernegger, C. and Blau, N., High frequency of tetrahydrobiopterin- responsiveness among hyperphenylalaninemias: a study of 1919 patients observed from 1988 to 2002, Mol. Genet. Metab., 2002, vol. 77, no. 4, pp. 304–313.

    Article  CAS  PubMed  Google Scholar 

  4. Fiege, B. and Blau, N., Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria, J. Pediatr., 2007, vol. 150, no. 6, pp. 627–630. doi 10.1016/j.jpeds.2007.02.017

    Article  CAS  PubMed  Google Scholar 

  5. Kure, S., Hou, D.C., Ohura, T., et al., Tetrahydrobiopter-in-responsive phenylalanine hydroxylase deficiency, J. Pediatr., 1999, vol. 135, no. 3, pp. 375–378.

    Article  CAS  PubMed  Google Scholar 

  6. Heintz, C., Cotton, R.G., and Blau, N., Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria, Hum. Mutat., 2013, vol. 34, no. 7, pp. 927–936. doi 10.1002/humu.22320

    Article  CAS  PubMed  Google Scholar 

  7. Dobrowolski, S.F., Heintz, C., Miller, T., et al., Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population, Mol. Genet. Metab., 2011, vol. 102, no. 2, pp. 116–121. doi 10.1016/j.ymgme.2010.11.158

    Article  CAS  PubMed  Google Scholar 

  8. Anichkina (Stepanova), A.A., Gavrilyuk, A.P., Tverskaya, S.M., and Polyakov, A.B., Analysis of the most common mutations in the PAH gene in patients with phenylketonuria, Med. Genet., 2003, vol. 2, no. 4, pp. 175–181.

    Google Scholar 

  9. Stepanova, A.A., Tverskaya, S.M., Zinchenko, R.A., and Polyakov, A.V., Molecular genetic study of the phenylalanine hydroxylase gene in the group of Russian phenylketonuria patients, Med. Genet., 2006, vol. 5, no. 2, pp. 32–39.

    Google Scholar 

  10. Gundorova, P., Stepanova, A.A., Shchagina, O.A., and Polyakov, A.B., Application of the new medical technologies “Detection of major PAH gene point mutations by multuplex ligase reaction” and “Detection of ten additional mutations in PAH gene by multuplex ligase reaction” in the DNA-diagnostics of phenylketonuria, Med. Genet., 2016, vol. 15, no. 2, pp. 29–36.

    Google Scholar 

  11. Blau, N., Yue, W., and Perez, B., PAHvdb. http://www.biopku.org/pah/.

  12. Zurfluh, M.R., Zschocke, J., Lindner, M., et al., Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency, Hum. Mutat., 2008, vol. 29, no. 1, pp. 167–175. doi 10.1002/humu.20637

    Article  PubMed  Google Scholar 

  13. Tighe, O., Dunican, D., O’Neill, C., et al., Genetic diversity within the R408W phenylketonuria mutation lineages in Europe, Hum. Mutat., 2003, vol. 21, no. 4, pp. 387–393.

    Article  CAS  PubMed  Google Scholar 

  14. Zschocke, J., Phenylketonuria mutations in Europe, Hum. Mutat., 2003, vol. 21, no. 4, pp. 345–356. doi 10.1002/humu.10192

    Article  CAS  PubMed  Google Scholar 

  15. Trunzo, R., Santacroce, R., D’Andrea, G., et al., Phenylalanine hydroxylase deficiency in south Italy: genotype—phenotype correlations, identification of a novel mutant PAH allele and prediction of BH4 responsiveness, Clin. Chim. Acta, 2015, vol. 450, pp. 51–55. doi 10.1016/j.cca.2015.07.014

    Article  CAS  PubMed  Google Scholar 

  16. Bayat, A., Yasmeen, S., Lund, A., et al., Mutational and phenotypical spectrum of phenylalanine hydroxylase deficiency in Denmark, Clin. Genet., 2015, vol. 90, no. 3, pp. 247–251. doi 10.1111/cge.12692

    Article  PubMed  Google Scholar 

  17. Stojiljkovic, M., Jovanovic, J., Djordjevic, M., et al., Molecular and phenotypic characteristics of patients with phenylketonuria in Serbia and Montenegro, Clin. Genet., 2006, vol. 70, no. 2, pp. 151–155.

    Article  CAS  PubMed  Google Scholar 

  18. Sterl, E., Paul, K., Paschke, E., et al., Prevalence of tetrahydrobiopterine (BH4)-responsive alleles among Austrian patients with PAH deficiency: comprehensive results from molecular analysis in 147 patients, J. Inherit. Metab. Dis., 2013, vol. 36, no. 1, pp. 7–13. doi 10.1007/s10545-012-9485-y

    Article  CAS  PubMed  Google Scholar 

  19. Groselj, U., Tansek, M.Z., Kovac, J., et al., Five novel mutations and two large deletions in a population analysis of the phenylalanine hydroxylase gene, Mol. Genet. Metab., 2012, vol. 106, no. 2, pp. 142–148. doi 10.1016/j.ymgme.2012.03.015

    Article  CAS  PubMed  Google Scholar 

  20. Zschocke, J., Preusse, A., Sarnavka, V., et al., The molecular basis of phenylalanine hydroxylase deficiency in Croatia, Hum. Mutat., 2003, vol. 21, no. 4, p. 399. doi 10.1002/humu.9115

    Article  PubMed  Google Scholar 

  21. Gemperle-Britschgi, C., Iorgulescu, D., Mager, M.A., et al., A novel common large genomic deletion and two new missense mutations identified in the Romanian phenylketonuria population, Gene, 2016, vol. 576, no. 1, part 1, pp. 182–188.

    Google Scholar 

  22. Polak, E., Ficek, A., Radvanszky, J., et al., Phenylalanine hydroxylase deficiency in the Slovak population: genotype—phenotype correlations and genotype-based predictions of BH4-responsiveness, Gene, 2013, vol. 526, no. 2, pp. 347–355. doi 10.1016/j.gene.2013. 05.057

    Article  CAS  PubMed  Google Scholar 

  23. Dobrowolski, S.F., Borski, K., Ellingson, C.C., et al., A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin, J. Hum. Genet., 2009, vol. 54, no. 6, pp. 335–339. doi 10.1038/jhg.2009.37

    Article  CAS  PubMed  Google Scholar 

  24. Kasnauskiene, J., Giannattasio, S., Lattanzio, P., et al., The molecular basis of phenylketonuria in Lithuania, Hum. Mutat., 2003, vol. 21, no. 4, p. 398. doi 10.1002/humu.9113

    Article  CAS  PubMed  Google Scholar 

  25. Pronina, N., Giannattasio, S., Lattanzio, P., et al., The molecular basis of phenylketonuria in Latvia, Hum. Mutat., 2003, vol. 21, no. 4, pp. 398–399. doi 10.1002/humu.9114

    Article  CAS  PubMed  Google Scholar 

  26. Gundorova, P., Stepanova, A.A., Makaov, A.Kh., et al., Mutation spectrum of the PAH gene in phenylketonuria patients in the Karachay-Cherkess Republic (Russia), Russ. J. Genet., 2016, vol. 52, no. 12, pp. 1282–1290. doi 10.1134/S1022795416110041

    Article  CAS  Google Scholar 

  27. Levy, H.L., Milanowski, A., Chakrapani, A., et al., Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study, Lancet, 2007, vol. 370, no. 9586, pp. 504–510. doi 10.1016/s0140- 6736(07)61234-3

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Gundorova.

Additional information

Original Russian Text © P. Gundorova, A.A. Stepanova, T.V. Bushueva, E.Yu. Belyashova, R.A. Zinchenko, S.S. Amelina, S.I. Kutsev, A.V. Polyakov, 2017, published in Genetika, 2017, Vol. 53, No. 6, pp. 732–739.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gundorova, P., Stepanova, A.A., Bushueva, T.V. et al. Genotyping of patients with phenylketonuria from different regions of Russia for determining BH4 responsiveness. Russ J Genet 53, 712–718 (2017). https://doi.org/10.1134/S1022795417060060

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1022795417060060

Keywords

Navigation